Role of Progesterone in Human Astrocytomas Growth

Author(s): Ignacio Camacho-Arroyo, Olivia Tania Hernandez-Hernandez, Edith Cabrera-Munoz

Journal Name: Current Topics in Medicinal Chemistry

Volume 11 , Issue 13 , 2011

Become EABM
Become Reviewer


Progesterone (P) participates in the regulation of several reproductive processes such as ovulation and sexual behavior, however, this hormone also participates in non-reproductive processes, such as neural excitability, learning and memory, and pathological processes such as cancer. P mainly elicits its effects by interaction with its intracellular receptor (PR), which is a ligand-activated transcription factor that modifies the expression of genes involved in the control of cell growth and proliferation, such as vascular endothelial growth factor and epidermal growth factor receptor. Two PR isoforms have been reported: PR-B and PR-A, which present different function and regulation. PR isoforms are expressed in U373 and D54 cell lines, which are derived from grades III and IV of human astrocytomas, respectively. In both cells lines P increases the number of astrocytomas cells. The PR antagonist, RU486, blocked P effects and its treatment alone significantly reduced human astrocytomas cell growth in vitro. The over-expression of PR-A in U373 cells significantly reduced P effects. These data suggest that P regulates human astrocytomas cell proliferation through the interaction with PR.

Keywords: growth factor receptor, U373 cells, expression of genes, ligand-activated transcription factor, neural excitability, cancer, cell growth, progesterone receptor isoforms, astrocytomas, Progesterone

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [1663 - 1667]
Pages: 5
DOI: 10.2174/156802611796117685
Price: $65

Article Metrics

PDF: 9